We are live on
!
Find out more
Rafferty Asset Management Portfolio holdings
AUM
$24.6B
1-Year Est. Return
47.06%
This Fund
S&P 500
This Quarter
Est. Return
+14.54%
1 Year Est. Return
+47.06%
3 Year Est. Return
+108.18%
5 Year Est. Return
+135.84%
10 Year Est. Return
+427.13%
AUM
$30.8B
AUM Growth
+$518M
(+1.7%)
Cap. Flow
-$2.73B
Cap. Flow
% of AUM
-8.84%
Top 10 Holdings %
Top 10 Hldgs %
39.95%
Holding
1,143
New
66
Increased
528
Reduced
508
Closed
39
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Astera Labs
ALAB
|
+$176M |
| 2 |
Credo Technology Group
CRDO
|
+$154M |
| 3 |
MACOM Technology Solutions
MTSI
|
+$71.5M |
| 4 |
Rambus
RMBS
|
+$69.5M |
| 5 |
NVMI
Nova
NVMI
|
+$68.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$386M |
| 2 |
NVIDIA
NVDA
|
+$300M |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$272M |
| 4 |
Broadcom
AVGO
|
+$248M |
| 5 |
Qualcomm
QCOM
|
+$184M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 45.44% |
| 2 | Financials | 9.98% |
| 3 | Consumer Discretionary | 8.65% |
| 4 | Healthcare | 3.7% |
| 5 | Industrials | 2.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
iShares MSCI Emerging Markets ETF
EEM
$28.8B
| $8.08M | 0.03% |
151,238
+6,938
| +5% | +$348K |
|
|
EXAS
327
DELISTED
Exact Sciences
EXAS
| $8.04M | 0.03% |
146,968
-25,740
| -15% | -$1.29M |
|
328
First Solar
FSLR
$25.8B
| $7.97M | 0.03% |
36,162
+1,143
| +3% | +$219K |
|
329
Insmed
INSM
$21.4B
| $7.94M | 0.03% |
55,159
-42,951
| -44% | -$5.26M |
|
330
Halozyme
HALO
$9.78B
| $7.94M | 0.03% |
108,214
-72,452
| -40% | -$4.81M |
|
331
BridgeBio Pharma
BBIO
$15.7B
| $7.89M | 0.03% |
151,990
-44,792
| -23% | -$2.18M |
|
332
Newmont
NEM
$99.9B
| $7.89M | 0.03% |
93,610
-704
| -0.7% | -$49.1K |
|
333
Hancock Whitney
HWC
$6.25B
| $7.85M | 0.03% |
125,308
+25,389
| +25% | +$1.56M |
|
334
Alnylam Pharmaceuticals
ALNY
$28.9B
| $7.82M | 0.03% |
17,151
-15,045
| -47% | -$6.13M |
|
335
Bank OZK
OZK
$5.65B
| $7.81M | 0.03% |
153,281
-24,199
| -14% | -$1.24M |
|
336
Meritage Homes
MTH
$4.69B
| $7.78M | 0.03% |
107,394
+49,101
| +84% | +$3.65M |
|
337
HCA Healthcare
HCA
$87.9B
| $7.75M | 0.03% |
18,184
-131
| -0.7% | -$50.8K |
|
338
Royal Caribbean
RCL
$87B
| $7.69M | 0.03% |
23,774
-717
| -3% | -$240K |
|
339
Targa Resources
TRGP
$57.1B
| $7.68M | 0.02% |
45,817
+1,606
| +4% | +$268K |
|
340
TG Therapeutics
TGTX
$7.27B
| $7.66M | 0.02% |
212,058
+23,838
| +13% | +$785K |
|
341
W.R. Berkley
WRB
$26.7B
| $7.64M | 0.02% |
99,718
+70
| +0.1% | +$4.98K |
|
342
Tyler Technologies
TYL
$12.7B
| $7.63M | 0.02% |
14,587
+503
| +4% | +$282K |
|
343
Natera
NTRA
$38.4B
| $7.63M | 0.02% |
47,408
-10,238
| -18% | -$1.62M |
|
344
Simon Property Group
SPG
$74B
| $7.63M | 0.02% |
40,657
+1,770
| +5% | +$306K |
|
|
RNAM
345
DELISTED
Avidity Biosciences
RNAM
| $7.56M | 0.02% |
173,480
+46,598
| +37% | +$1.88M |
|
346
T. Rowe Price
TROW
$24.2B
| $7.51M | 0.02% |
73,128
-127
| -0.2% | -$13.3K |
|
347
Atlantic Union Bankshares
AUB
$6.09B
| $7.5M | 0.02% |
212,461
-14,933
| -7% | -$508K |
|
348
3M
MMM
$92.1B
| $7.44M | 0.02% |
47,927
-660
| -1% | -$102K |
|
349
Zoetis
ZTS
$32.6B
| $7.41M | 0.02% |
50,648
+2,162
| +4% | +$327K |
|
350
Nike
NKE
$62.8B
| $7.4M | 0.02% |
106,191
+2,218
| +2% | +$165K |
|
Similar funds
CS
AF
SC
JG
Rafferty Asset Management's Q3 2025 Portfolio in Review
As of Q3 2025, Rafferty Asset Management held 1,143 positions worth $30.8B, up 1.7% from $30.3B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Rafferty Asset Management withdrew a net $2.73B in Q3 2025, closing 39 positions and reducing 508 holdings. Its most notable exit was Qorvo, an estimated $103M position sold in full.
By sector, the portfolio is most concentrated in Technology at 45% of assets, down from 49% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Rafferty Asset Management opened a new position in Astera Labs worth $210M.
- Rafferty Asset Management's largest Q3 2025 buy was Astera Labs: 1,070,475 shares worth $210M.
- Rafferty Asset Management added most to Invesco QQQ Trust in Q3 2025, an estimated $42.9M increase.
- Rafferty Asset Management's biggest Q3 2025 reduction was Advanced Micro Devices, cutting an estimated $386M.
- Rafferty Asset Management fully exited Qorvo in Q3 2025, selling an estimated $103M.
- Rafferty Asset Management's ten largest holdings make up 40% of its $30.8B portfolio in Q3 2025.
- Rafferty Asset Management opened 66 new positions and closed 39 in Q3 2025.
- Rafferty Asset Management's portfolio value rose 1.7% quarter-over-quarter to $30.8B.
Based on Rafferty Asset Management's 13F filing for Q3 2025, filed 12 Nov 2025.